MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening

Study summary

The primary objective of this pilot observational study is to evaluate the accrual and retention rate of a study population from a centralized lung cancer screening program to support MRI and blood-based biomarker research for lung cancer screening.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedLung MRI and Blood Draw

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 30, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Unknown

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Cedars-Sinai Medical Center

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: Cedars-Sinai Medical Center
Interventions being studied: Diagnostic Test: Lung MRI; Diagnostic Test: Blood Draw

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Ability to read and understand informed consent
Male or female adults who are at high risk for lung cancer and are enrolled in the centralized lung cancer screening program: Based on USPSTF guidelines: Age 50-80 with 20 or greater pack-year smoking story who continue to smoke or quit within the past 15 years without sign or symptoms of lung cancer. Or based on National Comprehensive Cancer Network (NCCN) guidelines but do not meet the USPSTF guidelines, age 50-unlimited
Found to have one or more lung nodules that is 6mm or greater on screening LDCT

Reasons someone may not be able to joinExclusion criteria

Persons with an active diagnosis of cancer
Persons with active signs or symptoms of lung cancer
Persons with mechanically, magnetically, or electrically activated implants, such as cardiac pacemakers, neurostimulators, and infusion pumps.
Persons with ferromagnetic implants and ferromagnetic foreign bodies, such as intracranial aneurysm clips, shrapnel and intraocular metal chips as these could become dislodged.
Persons who are pregnant, nursing, are implanted with intrauterine devices (IUD's) that are not MR-compatible
Persons unable to tolerate MRI imaging secondary to an inability to lie supine or severe claustrophobia.
Persons who are non-compliant with visit instructions, including inability to lie still, hold breath or follow procedure instructions

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Cedars-Sinai Medical CenterLos Angeles, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 30, 2023. Always confirm current availability with the study team.

View original record ↗